{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T01:30:21Z","timestamp":1778117421085,"version":"3.51.4"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NMRC Singapore","award":["NMRC\/1214\/2009"],"award-info":[{"award-number":["NMRC\/1214\/2009"]}]},{"DOI":"10.13039\/501100001459","name":"Ministry of Education - Singapore","doi-asserted-by":"publisher","award":["MOE\/2013-T2-2-130"],"award-info":[{"award-number":["MOE\/2013-T2-2-130"]}],"id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-024-01883-5","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T07:03:17Z","timestamp":1729321397000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lanthanide conjugate Pr-MPO elicits anti-cancer activity by targeting lysosomal machinery and inducing zinc-dependent cataplerosis"],"prefix":"10.1186","volume":"22","author":[{"given":"Gregory Lucien","family":"Bellot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Fivaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjiv K.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charanjit","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shazib","family":"Pervaiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,19]]},"reference":[{"issue":"1","key":"1883_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13046-020-01824-3","volume":"40","author":"M Akman","year":"2021","unstructured":"Akman M, Belisario DC, Salaroglio IC, et al. Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons. J Exp Clin Cancer Res. 2021;40(1):28.","journal-title":"J Exp Clin Cancer Res"},{"key":"1883_CR2","doi-asserted-by":"publisher","first-page":"100645","DOI":"10.1016\/j.drup.2019.100645","volume":"46","author":"YG Assaraf","year":"2019","unstructured":"Assaraf YG, Brozovic A, Gon\u00e7alves AC, et al. The multi-factorial nature of clinical multidrug resistance in cancer. Drug Resist Updat. 2019;46:100645.","journal-title":"Drug Resist Updat"},{"issue":"2","key":"1883_CR3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/ijc.30669","volume":"141","author":"DH Bach","year":"2017","unstructured":"Bach DH, Hong JY, Park HJ, Lee SK. The role of exosomes and miRNAs in drug-resistance of cancer cells. Int J Cancer. 2017;141(2):220\u201330.","journal-title":"Int J Cancer"},{"issue":"22","key":"1883_CR4","doi-asserted-by":"publisher","first-page":"12727","DOI":"10.1093\/nar\/gkaa1110","volume":"48","author":"SJF Chong","year":"2020","unstructured":"Chong SJF, Iskandar K, Lai JXH, et al. Serine-70 phosphorylated Bcl-2 prevents oxidative stress-induced DNA damage by modulating the mitochondrial redox metabolism. Nucleic Acids Res. 2020;48(22):12727\u201345.","journal-title":"Nucleic Acids Res"},{"key":"1883_CR5","doi-asserted-by":"crossref","unstructured":"Chong SJF, Zhu F, Dashevsky O et al. Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies. J Clin Invest. 2023;133(22).","DOI":"10.1172\/JCI170169"},{"key":"1883_CR6","doi-asserted-by":"publisher","first-page":"101076","DOI":"10.1016\/j.redox.2018.101076","volume":"25","author":"J Hirpara","year":"2019","unstructured":"Hirpara J, Eu JQ, Tan JKM, et al. Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance. Redox Biol. 2019;25:101076.","journal-title":"Redox Biol"},{"issue":"8","key":"1883_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer. 2007;7(8):573\u201384.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1883_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41568-020-00308-y","volume":"21","author":"S Rottenberg","year":"2021","unstructured":"Rottenberg S, Disler C, Perego P. The rediscovery of platinum-based cancer therapy. Nat Rev Cancer. 2021;21(1):37\u201350.","journal-title":"Nat Rev Cancer"},{"key":"1883_CR9","doi-asserted-by":"crossref","unstructured":"Mohapatra P, Shriwas O, Mohanty S et al. CMTM6 drives cisplatin resistance by regulating wnt signaling through the ENO-1\/AKT\/GSK3\u03b2 axis. JCI Insight. 2021;6(4).","DOI":"10.1172\/jci.insight.143643"},{"key":"1883_CR10","doi-asserted-by":"crossref","unstructured":"Xiao Y, Lin FT, Lin WC. ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer. Proc Natl Acad Sci U S A. 2021;118(3).","DOI":"10.1073\/pnas.2015808118"},{"key":"1883_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejmech.2017.04.007","volume":"142","author":"T Lazarevi\u0107","year":"2017","unstructured":"Lazarevi\u0107 T, Rilak A, Bugar\u010di\u0107 \u017dD. Platinum, palladium, gold and ruthenium complexes as anticancer agents: current clinical uses, cytotoxicity studies and future perspectives. Eur J Med Chem. 2017;142:8\u201331.","journal-title":"Eur J Med Chem"},{"issue":"13","key":"1883_CR12","doi-asserted-by":"publisher","first-page":"6012","DOI":"10.1021\/acs.jmedchem.5b01975","volume":"59","author":"RD Teo","year":"2016","unstructured":"Teo RD, Termini J, Gray HB. Lanthanides: applications in Cancer diagnosis and therapy. J Med Chem. 2016;59(13):6012\u201324.","journal-title":"J Med Chem"},{"issue":"4","key":"1883_CR13","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.18388\/abp.2000_3963","volume":"47","author":"A Pa\u0142asz","year":"2000","unstructured":"Pa\u0142asz A, Czekaj P. Toxicological and cytophysiological aspects of lanthanides action. Acta Biochim Pol. 2000;47(4):1107\u201314.","journal-title":"Acta Biochim Pol"},{"issue":"6","key":"1883_CR14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1039\/b516376p","volume":"35","author":"M Bottrill","year":"2006","unstructured":"Bottrill M, Kwok L, Long NJ. Lanthanides in magnetic resonance imaging [10.1039\/B516376P]. Chem Soc Rev. 2006;35(6):557\u201371.","journal-title":"Chem Soc Rev"},{"issue":"4","key":"1883_CR15","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3390\/cancers4041067","volume":"4","author":"R Naccache","year":"2012","unstructured":"Naccache R, Rodr\u00edguez EM, Bogdan N, et al. High resolution fluorescence imaging of cancers using lanthanide ion-doped upconverting nanocrystals. Cancers (Basel). 2012;4(4):1067\u2013105.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1883_CR16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.saa.2008.09.019","volume":"72","author":"XM Shi","year":"2009","unstructured":"Shi XM, Tang RR, Gu GL, Huang KL. Synthesis and fluorescence properties of lanthanide(III) complexes of a novel bis(pyrazolyl-carboxyl)pyridine-based ligand. Spectrochim Acta Mol Biomol Spectrosc. 2009;72(1):198\u2013203.","journal-title":"Spectrochim Acta Mol Biomol Spectrosc"},{"issue":"6","key":"1883_CR17","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1039\/b509608c","volume":"35","author":"SP Fricker","year":"2006","unstructured":"Fricker SP. The therapeutic application of lanthanides [10.1039\/B509608C]. Chem Soc Rev. 2006;35(6):524\u201333.","journal-title":"Chem Soc Rev"},{"key":"1883_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0010-8545(99)00072-7","volume":"190\u2013192","author":"K Wang","year":"1999","unstructured":"Wang K, Li R, Cheng Y, Zhu B. Lanthanides\u2014the future drugs? Coordination Chemistry Reviews. 1999;190\u2013192:297\u2013308.","journal-title":"Coordination Chemistry Reviews."},{"issue":"8","key":"1883_CR19","doi-asserted-by":"publisher","first-page":"678","DOI":"10.2174\/138955711796268804","volume":"11","author":"J Zhang","year":"2011","unstructured":"Zhang J, Li Y, Hao X, et al. Recent progress in therapeutic and diagnostic applications of lanthanides. Mini Rev Med Chem. 2011;11(8):678\u201394.","journal-title":"Mini Rev Med Chem"},{"issue":"1","key":"1883_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1021\/acsami.8b20334","volume":"11","author":"LRH Gerken","year":"2019","unstructured":"Gerken LRH, Keevend K, Zhang Y, et al. Lanthanide-Doped Hafnia nanoparticles for Multimodal Theranostics: tailoring the Physicochemical Properties and interactions with Biological entities. ACS Appl Mater Interfaces. 2019;11(1):437\u201348.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"26","key":"1883_CR21","doi-asserted-by":"publisher","first-page":"9756","DOI":"10.1073\/pnas.0603758103","volume":"103","author":"O Alpt\u00fcrk","year":"2006","unstructured":"Alpt\u00fcrk O, Rusin O, Fakayode SO, et al. Lanthanide complexes as fluorescent indicators for neutral sugars and cancer biomarkers. Proc Natl Acad Sci U S A. 2006;103(26):9756\u201360.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1093","key":"1883_CR22","first-page":"20180365","volume":"92","author":"F Lux","year":"2019","unstructured":"Lux F, Tran VL, Thomas E, et al. AGuIX(\u00ae) from bench to bedside-transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine. Br J Radiol. 2019;92(1093):20180365.","journal-title":"Br J Radiol"},{"key":"1883_CR23","doi-asserted-by":"publisher","first-page":"5988","DOI":"10.1038\/ncomms6988","volume":"6","author":"Y Liu","year":"2015","unstructured":"Liu Y, Chen C, Qian P, et al. Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor. Nat Commun. 2015;6:5988.","journal-title":"Nat Commun"},{"issue":"2","key":"1883_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1042\/bj1400143","volume":"140","author":"KC Reed","year":"1974","unstructured":"Reed KC, Bygrave FL. The inhibition of mitochondrial calcium transport by lanthanides and ruthenium red. Biochem J. 1974;140(2):143\u201355.","journal-title":"Biochem J"},{"issue":"5","key":"1883_CR25","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1039\/c8mt00317c","volume":"11","author":"LL Brayshaw","year":"2019","unstructured":"Brayshaw LL, Smith RCG, Badaoui M, et al. Lanthanides compete with calcium for binding to cadherins and inhibit cadherin-mediated cell adhesion [10.1039\/C8MT00317C]. Metallomics. 2019;11(5):914\u201324.","journal-title":"Metallomics"},{"issue":"2","key":"1883_CR26","first-page":"119","volume":"5","author":"AA Palizban","year":"2010","unstructured":"Palizban AA, Sadeghi-Aliabadi H, Abdollahpour F. Effect of cerium lanthanide on Hela and MCF-7 cancer cell growth in the presence of transferring. Res Pharm Sci. 2010;5(2):119\u201325.","journal-title":"Res Pharm Sci"},{"key":"1883_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccr.2018.05.012","volume":"370","author":"MT Kaczmarek","year":"2018","unstructured":"Kaczmarek MT, Zabiszak M, Nowak M, Jastrzab R. Lanthanides Schiff base complexes, applications in cancer diagnosis, therapy, and antibacterial activity. Coord Chem Rev. 2018;370:42\u201354.","journal-title":"Coord Chem Rev."},{"key":"1883_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.tiv.2017.09.024","volume":"46","author":"A Benedetto","year":"2018","unstructured":"Benedetto A, Bocca C, Brizio P, et al. Effects of the rare elements lanthanum and cerium on the growth of colorectal and hepatic cancer cell lines. Toxicol Vitro. 2018;46:9\u201318.","journal-title":"Toxicol Vitro"},{"issue":"38","key":"1883_CR29","doi-asserted-by":"publisher","first-page":"14125","DOI":"10.1021\/ja404243v","volume":"135","author":"A Abdukayum","year":"2013","unstructured":"Abdukayum A, Chen JT, Zhao Q, Yan XP. Functional near infrared-emitting Cr3+\/Pr3\u2009+\u2009co-doped zinc gallogermanate persistent luminescent nanoparticles with superlong afterglow for in vivo targeted bioimaging. J Am Chem Soc. 2013;135(38):14125\u201333.","journal-title":"J Am Chem Soc"},{"issue":"40","key":"1883_CR30","doi-asserted-by":"publisher","first-page":"20759","DOI":"10.1039\/D0NR06577C","volume":"12","author":"GA Mandl","year":"2020","unstructured":"Mandl GA, Van der Heggen D, Cooper DR, et al. On a local (de-)trapping model for highly doped Pr3\u2009+\u2009radioluminescent and persistent luminescent nanoparticles [10.1039\/D0NR06577C]. Nanoscale. 2020;12(40):20759\u201366.","journal-title":"Nanoscale"},{"issue":"21","key":"1883_CR31","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.1002\/anie.200604827","volume":"46","author":"S Shrestha","year":"2007","unstructured":"Shrestha S, Yeung CM, Mills CE, et al. Chemically immobilized single-stranded oligonucleotides on praseodymium oxide nanoparticles as an unlabeled DNA sensor probe using impedance. Angew Chem Int Ed Engl. 2007;46(21):3855\u20139.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"1883_CR32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1667\/RR15491.1","volume":"193","author":"M M\u00fcller","year":"2020","unstructured":"M\u00fcller M, Espinoza S, J\u00fcstel T, et al. UVC-Emitting LuPO(4):pr(3+) nanoparticles decrease Radiation Resistance of Hypoxic Cancer cells. Radiat Res. 2020;193(1):82\u20137.","journal-title":"Radiat Res"},{"issue":"6","key":"1883_CR33","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.brachy.2013.06.007","volume":"12","author":"MC Ferreira","year":"2013","unstructured":"Ferreira MC, Podder TK, Rasmussen KH, Jung JW. Praseodymium-142 microspheres for brachytherapy of nonresectable hepatic tumors. Brachytherapy. 2013;12(6):654\u201364.","journal-title":"Brachytherapy."},{"key":"1883_CR34","doi-asserted-by":"publisher","first-page":"109150","DOI":"10.1016\/j.radphyschem.2020.109150","volume":"177","author":"N Koyuncu","year":"2020","unstructured":"Koyuncu N, Reyhancan \u0130A. Dose evaluation of 142Pr radioisotope by Monte Carlo method in eye brachytherapy. Radiat Phys Chem. 2020;177:109150.","journal-title":"Radiat Phys Chem."},{"key":"1883_CR35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.apradiso.2017.07.040","volume":"134","author":"E Yeltepe","year":"2018","unstructured":"Yeltepe E, Y\u00fccel H. Standardization of 142Pr activity concentration. Appl Radiat Isot. 2018;134:263\u20138.","journal-title":"Appl Radiat Isot."},{"issue":"51","key":"1883_CR36","doi-asserted-by":"publisher","first-page":"83964","DOI":"10.18632\/oncotarget.13336","volume":"7","author":"JL Hirpara","year":"2016","unstructured":"Hirpara JL, Loh T, Ng SB, et al. Aberrant localization of apoptosis protease activating factor-1 in lipid raft sub-domains of diffuse large B cell lymphomas. Oncotarget. 2016;7(51):83964\u201375.","journal-title":"Oncotarget"},{"issue":"2","key":"1883_CR37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/cyto.a.20362","volume":"71","author":"AL Holme","year":"2007","unstructured":"Holme AL, Yadav SK, Pervaiz S. Automated laser scanning cytometry: a powerful tool for multi-parameter analysis of drug-induced apoptosis. Cytometry A. 2007;71(2):80\u20136.","journal-title":"Cytometry A"},{"key":"1883_CR38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.canlet.2021.11.025","volume":"526","author":"SF Lee","year":"2022","unstructured":"Lee SF, Hirpara JL, Qu J, et al. Identification of a novel catalytic inhibitor of topoisomerase II alpha that engages distinct mechanisms in p53(wt) or p53(-\/-) cells to trigger G2\/M arrest and senescence. Cancer Lett. 2022;526:284\u2013303.","journal-title":"Cancer Lett"},{"key":"1883_CR39","doi-asserted-by":"crossref","unstructured":"Li RJ, Xu J, Fu C et al. Regulation of mTORC1 by lysosomal calcium and calmodulin. Elife. 2016;5.","DOI":"10.7554\/eLife.19360"},{"issue":"4","key":"1883_CR40","doi-asserted-by":"publisher","first-page":"581","DOI":"10.4161\/auto.23568","volume":"9","author":"K Porter","year":"2013","unstructured":"Porter K, Nallathambi J, Lin Y, Liton PB. Lysosomal basification and decreased autophagic flux in oxidatively stressed trabecular meshwork cells: implications for glaucoma pathogenesis. Autophagy. 2013;9(4):581\u201394.","journal-title":"Autophagy"},{"issue":"1","key":"1883_CR41","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1038\/s41467-018-05261-x","volume":"9","author":"E Persi","year":"2018","unstructured":"Persi E, Duran-Frigola M, Damaghi M, et al. Systems analysis of intracellular pH vulnerabilities for cancer therapy. Nat Commun. 2018;9(1):2997.","journal-title":"Nat Commun"},{"issue":"11","key":"1883_CR42","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1158\/2159-8290.CD-17-0741","volume":"7","author":"VW Rebecca","year":"2017","unstructured":"Rebecca VW, Nicastri MC, McLaughlin N, et al. A Unified Approach to Targeting the Lysosome\u2019s degradative and Growth Signaling roles. Cancer Discov. 2017;7(11):1266\u201383.","journal-title":"Cancer Discov"},{"issue":"4","key":"1883_CR43","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41401-020-0445-z","volume":"42","author":"Z Li","year":"2021","unstructured":"Li Z, Zhu YT, Xiang M, et al. Enhanced lysosomal function is critical for paclitaxel resistance in cancer cells: reversed by artesunate. Acta Pharmacol Sin. 2021;42(4):624\u201332.","journal-title":"Acta Pharmacol Sin"},{"issue":"9","key":"1883_CR44","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1007\/s00125-003-1171-z","volume":"46","author":"I Chang","year":"2003","unstructured":"Chang I, Cho N, Koh JY, Lee MS. Pyruvate inhibits zinc-mediated pancreatic islet cell death and diabetes. Diabetologia. 2003;46(9):1220\u20137.","journal-title":"Diabetologia"},{"issue":"20","key":"1883_CR45","doi-asserted-by":"publisher","first-page":"Rc171","DOI":"10.1523\/JNEUROSCI.21-20-j0002.2001","volume":"21","author":"JY Lee","year":"2001","unstructured":"Lee JY, Kim YH, Koh JY. Protection by pyruvate against transient forebrain ischemia in rats. J Neurosci. 2001;21(20):Rc171.","journal-title":"J Neurosci"},{"issue":"5","key":"1883_CR46","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1167\/iovs.03-1315","volume":"45","author":"MH Yoo","year":"2004","unstructured":"Yoo MH, Lee JY, Lee SE, et al. Protection by pyruvate of rat retinal cells against zinc toxicity in vitro, and pressure-induced ischemia in vivo. Invest Ophthalmol Vis Sci. 2004;45(5):1523\u201330.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1883_CR47","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1046\/j.1471-4159.2003.01678.x","volume":"85","author":"KE Dineley","year":"2003","unstructured":"Dineley KE, Votyakova TV, Reynolds IJ. Zinc inhibition of cellular energy production: implications for mitochondria and neurodegeneration. J Neurochem. 2003;85(3):563\u201370.","journal-title":"J Neurochem"},{"issue":"11","key":"1883_CR48","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/pros.20617","volume":"67","author":"BK Matheson","year":"2007","unstructured":"Matheson BK, Adams JL, Zou J, et al. Effect of metabolic inhibitors on ATP and citrate content in PC3 prostate cancer cells. Prostate. 2007;67(11):1211\u20138.","journal-title":"Prostate"},{"issue":"3","key":"1883_CR49","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10534-017-0009-y","volume":"30","author":"K Murakami","year":"2017","unstructured":"Murakami K, Yoshino M. Zinc inhibition of pyruvate kinase of M-type isozyme. Biometals. 2017;30(3):335\u201340.","journal-title":"Biometals"},{"issue":"9","key":"1883_CR50","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1523\/JNEUROSCI.20-09-03139.2000","volume":"20","author":"CT Sheline","year":"2000","unstructured":"Sheline CT, Behrens MM, Choi DW. Zinc-induced cortical neuronal death: contribution of energy failure attributable to loss of NAD(+) and inhibition of glycolysis. J Neurosci. 2000;20(9):3139\u201346.","journal-title":"J Neurosci"},{"issue":"1","key":"1883_CR51","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1128\/JVI.01543-08","volume":"83","author":"BM Krenn","year":"2009","unstructured":"Krenn BM, Gaudernak E, Holzer B, et al. Antiviral activity of the zinc ionophores pyrithione and hinokitiol against picornavirus infections. J Virol. 2009;83(1):58\u201364.","journal-title":"J Virol"},{"issue":"1","key":"1883_CR52","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.antiviral.2013.07.001","volume":"100","author":"M Qiu","year":"2013","unstructured":"Qiu M, Chen Y, Chu Y, et al. Zinc ionophores pyrithione inhibits herpes simplex virus replication through interfering with proteasome function and NF-\u03baB activation. Antiviral Res. 2013;100(1):44\u201353.","journal-title":"Antiviral Res"},{"issue":"11","key":"1883_CR53","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/iub.253","volume":"61","author":"WQ Ding","year":"2009","unstructured":"Ding WQ, Lind SE. Metal ionophores - an emerging class of anticancer drugs. IUBMB Life. 2009;61(11):1013\u20138.","journal-title":"IUBMB Life"},{"issue":"9","key":"1883_CR54","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1097\/JTO.0b013e3182208fac","volume":"6","author":"KW Kim","year":"2011","unstructured":"Kim KW, Speirs CK, Jung DK, Lu B. The zinc ionophore PCI-5002 radiosensitizes non-small cell lung cancer cells by enhancing autophagic cell death. J Thorac Oncol. 2011;6(9):1542\u201352.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"1883_CR55","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1042\/BJ20081421","volume":"417","author":"H Yu","year":"2009","unstructured":"Yu H, Zhou Y, Lind SE, Ding WQ. Clioquinol targets zinc to lysosomes in human cancer cells. Biochem J. 2009;417(1):133\u20139.","journal-title":"Biochem J"},{"issue":"1","key":"1883_CR56","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12989-020-00379-7","volume":"17","author":"Z Liu","year":"2020","unstructured":"Liu Z, Lv X, Xu L, et al. Zinc oxide nanoparticles effectively regulate autophagic cell death by activating autophagosome formation and interfering with their maturation. Part Fibre Toxicol. 2020;17(1):46.","journal-title":"Part Fibre Toxicol"},{"issue":"2","key":"1883_CR57","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.bbamcr.2011.09.013","volume":"1823","author":"RE Carraway","year":"2012","unstructured":"Carraway RE, Dobner PR. Zinc pyrithione induces ERK- and PKC-dependent necrosis distinct from TPEN-induced apoptosis in prostate cancer cells. Biochim Biophys Acta. 2012;1823(2):544\u201357.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1883_CR58","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1080\/21691401.2020.1770266","volume":"48","author":"M Chen","year":"2020","unstructured":"Chen M, Ding Y, Ke Y, et al. Anti-tumour activity of zinc ionophore pyrithione in human ovarian cancer cells through inhibition of proliferation and migration and promotion of lysosome-mitochondrial apoptosis. Artif Cells Nanomed Biotechnol. 2020;48(1):824\u201333.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"2","key":"1883_CR59","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10534-010-9302-8","volume":"23","author":"E Rudolf","year":"2010","unstructured":"Rudolf E, Cervinka M. Zinc pyrithione induces cellular stress signaling and apoptosis in Hep-2 cervical tumor cells: the role of mitochondria and lysosomes. Biometals. 2010;23(2):339\u201354.","journal-title":"Biometals"},{"issue":"8","key":"1883_CR60","doi-asserted-by":"publisher","first-page":"13942","DOI":"10.18632\/oncotarget.14572","volume":"8","author":"C Zhao","year":"2017","unstructured":"Zhao C, Chen X, Yang C, et al. Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases. Oncotarget. 2017;8(8):13942\u201356.","journal-title":"Oncotarget"},{"issue":"8","key":"1883_CR61","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1016\/j.molonc.2015.05.005","volume":"9","author":"G Srivastava","year":"2015","unstructured":"Srivastava G, Matta A, Fu G, et al. Anticancer activity of pyrithione zinc in oral cancer cells identified in small molecule screens and xenograft model: implications for oral cancer therapy. Mol Oncol. 2015;9(8):1720\u201335.","journal-title":"Mol Oncol"},{"key":"1883_CR62","doi-asserted-by":"publisher","first-page":"600089","DOI":"10.3389\/fnmol.2020.600089","volume":"13","author":"A Granzotto","year":"2020","unstructured":"Granzotto A, Canzoniero LMT, Sensi SL. A neurotoxic Menage-a-trois: glutamate, calcium, and Zinc in the Excitotoxic Cascade. Front Mol Neurosci. 2020;13:600089.","journal-title":"Front Mol Neurosci"},{"key":"1883_CR63","doi-asserted-by":"publisher","unstructured":"Hershfinkel M. Cross-talk between zinc and calcium regulates ion transport: a role for the zinc receptor, ZnR\/GPR39.\u00a0J Physiol. 2024;602(8):1579\u201394. https:\/\/doi.org\/10.1113\/JP283834.","DOI":"10.1113\/JP283834"},{"key":"1883_CR64","doi-asserted-by":"publisher","first-page":"577958","DOI":"10.3389\/fnins.2020.577958","volume":"14","author":"YH Kim","year":"2020","unstructured":"Kim YH, Eom JW, Koh JY. Mechanism of Zinc Excitotoxicity: a focus on AMPK. Front Neurosci. 2020;14:577958.","journal-title":"Front Neurosci"},{"issue":"10","key":"1883_CR65","doi-asserted-by":"publisher","first-page":"7430","DOI":"10.1074\/jbc.M109.040485","volume":"285","author":"K Inoue","year":"2010","unstructured":"Inoue K, Branigan D, Xiong ZG. Zinc-induced neurotoxicity mediated by transient receptor potential melastatin 7 channels. J Biol Chem. 2010;285(10):7430\u20139.","journal-title":"J Biol Chem"},{"issue":"41","key":"1883_CR66","doi-asserted-by":"publisher","first-page":"10430","DOI":"10.1523\/JNEUROSCI.1588-06.2006","volume":"26","author":"CJ Stork","year":"2006","unstructured":"Stork CJ, Li YV. Intracellular zinc elevation measured with a calcium-specific indicator during ischemia and reperfusion in rat hippocampus: a question on calcium overload. J Neurosci. 2006;26(41):10430\u20137.","journal-title":"J Neurosci"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01883-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-024-01883-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01883-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T08:03:34Z","timestamp":1729325014000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-024-01883-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,19]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1883"],"URL":"https:\/\/doi.org\/10.1186\/s12964-024-01883-5","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,19]]},"assertion":[{"value":"15 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"509"}}